Qingling Duan

Dr. Duan’s research seeks to identify genomic factors that regulate drug response or susceptibility to multifactorial diseases such as asthma, COPD, cardiovascular diseases and various cancers. Her current research integrates variable biomedical data (genomics, transcriptomics and epigenomics) for gene-based, network-based as well as gene-environment interaction analyses to identify novel genomic regulators of disease risk (e.g., asthma, COPD, diabetes) and other clinical outcomes (e.g., symptom severity, lung function).

CHILD Study Investigator

Dr. Duan is a co-investigator on the CIHR-funded project “Gene and environment effects on lung health and risk for chronic respiratory disease, asthma and COPD.”